{"title":"Response to Letter to the Editor from Hooper: Cardio-cerebrovascular Outcomes in MODY, Type 1 Diabetes, and Type 2 Diabetes: A Prospective Cohort Study","authors":"Hui-Xuan Wu, Tian-Yao Chu, Junaid Iqbal, Hong-Li Jiang, Long Li, Yan-Xuan Wu, Hou-De Zhou","doi":"10.1210/clinem/dgad720","DOIUrl":"https://doi.org/10.1210/clinem/dgad720","url":null,"abstract":"","PeriodicalId":222304,"journal":{"name":"The Journal of Clinical Endocrinology & Metabolism","volume":"1 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138585638","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Natalie Hernandez, Yuliya Lokhnygina, M. Ramaker, Olga Ilkayeva, Michael J Muehlbauer, Matthew L. Crawford, Russell P Grant, Daniel S Hsia, Nina Jain, James R Bain, Sarah Armstrong, C. Newgard, Michael Freemark, Pinar Gumus Balikcioglu
{"title":"Sex differences in branched-chain amino acid and tryptophan metabolism and pathogenesis of youth-onset type 2 diabetes","authors":"Natalie Hernandez, Yuliya Lokhnygina, M. Ramaker, Olga Ilkayeva, Michael J Muehlbauer, Matthew L. Crawford, Russell P Grant, Daniel S Hsia, Nina Jain, James R Bain, Sarah Armstrong, C. Newgard, Michael Freemark, Pinar Gumus Balikcioglu","doi":"10.1210/clinem/dgad708","DOIUrl":"https://doi.org/10.1210/clinem/dgad708","url":null,"abstract":"\u0000 \u0000 \u0000 Insulin resistance is associated with elevations in plasma branched-chain amino acids (BCAAs). BCAAs compete with aromatic amino acids (AAA) including tryptophan for uptake into β-cells. To explore relationships between BCAAs and tryptophan metabolism, adiposity, and glucose tolerance we compared urine metabolites in overweight/obese youth with T2D to those in non-diabetic overweight/obese and lean youth.\u0000 \u0000 \u0000 \u0000 Metabolites were measured in 24-hr and first-morning urine samples of 56 non-diabetic adolescents with overweight/obesity, 42 adolescents with T2D, and 43 lean controls, ages 12-21 yr. Group differences were assessed by Kruskal Wallis or ANOVA.\u0000 \u0000 \u0000 \u0000 Groups were comparable for age, pubertal status, and ethnicity. Youth with T2D were predominantly female and had highest percent body fat. BCAAs, branched-chain ketoacids (BCKAs), tryptophan, and kynurenine were higher in urine of subjects with T2D. There were no differences between lean controls and non-diabetic youth with overweight/obesity. T2D was associated with diversion of tryptophan from the serotonin to the kynurenine pathway, with higher urinary kynurenine/serotonin ratio and lower serotonin/tryptophan and 5-hydroxyindoleacetic acid (5-HIAA)/kynurenine ratios. Urinary BCAAs, BCKAs, tryptophan, and ratios reflecting diversion to the kynurenine pathway correlated positively with metrics of body fat and HbA1c. Increases in these metabolites in the obese T2D group were more pronounced and statistically significant only in adolescent girls.\u0000 \u0000 \u0000 \u0000 Increases in urinary BCAAs and BCKAs in adolescent females with T2D are accompanied by diversion of tryptophan metabolism from the serotonin to the kynurenine pathway. These adaptations associate with higher risks of T2D in obese adolescent females than adolescent males.\u0000","PeriodicalId":222304,"journal":{"name":"The Journal of Clinical Endocrinology & Metabolism","volume":"63 20","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138587336","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Terence Garner, Peter Clayton, Michael Højby, Philip G. Murray, Adam Stevens
{"title":"Gene expression signatures predict first-year response to somapacitan treatment in children with GH deficiency","authors":"Terence Garner, Peter Clayton, Michael Højby, Philip G. Murray, Adam Stevens","doi":"10.1210/clinem/dgad717","DOIUrl":"https://doi.org/10.1210/clinem/dgad717","url":null,"abstract":"\u0000 \u0000 \u0000 The pre-treatment blood transcriptome predicts growth response to daily GH therapy with high accuracy.\u0000 \u0000 \u0000 \u0000 Investigate response prediction using pre-treatment transcriptome in children with GH deficiency (GHD) treated with once-weekly somapacitan, a novel long-acting GH.\u0000 \u0000 \u0000 \u0000 REAL4 is a randomised, multinational, open-labelled, active-controlled parallel group phase 3 trial, comprising a 52-week main phase and an ongoing 3-year safety extension (NCT03811535).\u0000 \u0000 \u0000 \u0000 128/200 treatment-naïve prepubertal children with GHD consented to baseline blood transcriptome profiling.\u0000 \u0000 \u0000 \u0000 Randomized 2:1 to subcutaneous somapacitan (0.16 mg/kg/week) or daily GH (0.034 mg/kg/day).\u0000 \u0000 \u0000 \u0000 Differential RNA-seq analysis and machine learning to predict therapy response.\u0000 \u0000 \u0000 \u0000 121/128 samples passed quality control. Children treated with somapacitan (n = 76) or daily GH (n = 45) were categorised based on fastest and slowest growing quartiles at week 52. Prediction of height velocity (HV; cm/year) was excellent for both treatments (OOB AUC: 0.98–0.99; validation AUC: 0.83-0.84), as was prediction of secondary markers of growth response: HV SD score (SDS) (0.99-1.0; 0.75-0.78), change from baseline height SDS (ΔHSDS) (0.98-1.0; 0.61-0.75) and change from baseline insulin-like growth factor-I SDS (ΔIGF-I SDS) (0.96-1.0; 0.85-0.88). Genes previously identified as predictive of GH therapy response were consistently better at predicting the fastest growers in both treatments in this study (OOB AUC: 0.93-0.97) than the slowest (0.67-0.85).\u0000 \u0000 \u0000 \u0000 Pre-treatment transcriptome predicts first-year growth response in somapacitan-treated children with GHD. A common set of genes can predict the treatment response to both once-weekly somapacitan and conventional daily GH. This approach could potentially be developed into a clinically-applicable pre-treatment test to improve clinical management.\u0000","PeriodicalId":222304,"journal":{"name":"The Journal of Clinical Endocrinology & Metabolism","volume":"30 16","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138588874","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
V. Barrios, Álvaro Martín-Rivada, S. Guerra-Cantera, Ana Campillo-Calatayud, Ricardo Camarneiro, Montserrat Graell, J. Chowen, Jesús Argente
{"title":"Reduction in pappalysin-2 levels and lower IGF-I bioavailability in female adolescents with anorexia nervosa","authors":"V. Barrios, Álvaro Martín-Rivada, S. Guerra-Cantera, Ana Campillo-Calatayud, Ricardo Camarneiro, Montserrat Graell, J. Chowen, Jesús Argente","doi":"10.1210/clinem/dgad713","DOIUrl":"https://doi.org/10.1210/clinem/dgad713","url":null,"abstract":"\u0000 \u0000 \u0000 Anorexia nervosa (AN) can cause severe undernutrition associated with alterations in the insulin-like growth factor (IGF) axis. Pappalysins (PAPP-A, PAPP-A2) and stanniocalcins (STC-1, STC-2) modulate IGF binding-protein (IGFBP) cleavage and IGF bioavailability, but their implications in AN are unknown.\u0000 \u0000 \u0000 \u0000 We determined serum levels of PAPP-As and STCs in relationship with classical IGF axis parameters in female adolescents with AN, and their association with nutritional status and secondary amenorrhea.\u0000 \u0000 \u0000 \u0000 Parameters of the IGF axis were determined in fasting serum samples of 68 female adolescents with AN at diagnosis and 62 sex- and age-matched controls. Standardized body mass index (BMI) and bone mineral density (BMD) were calculated.\u0000 \u0000 \u0000 \u0000 Patients with AN had lower concentrations of total and free IGF-I, total IGFBP-3, ALS, insulin, PAPP-A2, STC-1 and STC-2 and higher levels of IGF-II and IGFBP-2. Their free/total IGF-I ratio was decreased and the intact/total IGFBP-3 and -4 ratios increased. BMI was directly related to total IGF-I, and intact IGFBP-3, and inversely with IGFBP-2 and intact IGFBP-4. Weight loss was directly correlated with intact IGFBP-4, and negatively with intact IGFBP-3, ALS, STC-2 and PAPP-A2 concentrations. BMD was directly related to intact IGFBP-3, and inversely with intact IGFBP-4 and PAPP-A2 levels. Patients with amenorrhea had lower levels of total IGF-I and IGFBP-3 than those with menses.\u0000 \u0000 \u0000 \u0000 The reduction of PAPP-A2 in patients with AN may be involved in a decline in IGFBP cleavage, which could underlie the decrease in IGF-I bioavailability that is influenced by nutritional status and amenorrhea.\u0000","PeriodicalId":222304,"journal":{"name":"The Journal of Clinical Endocrinology & Metabolism","volume":"31 9","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138589901","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Association between a History of Breast Cancer and Decreased Thyroid Cancer-specific Mortality","authors":"Shuhuang Lin, Zhuo Wang, Mingzhao Xing","doi":"10.1210/clinem/dgad722","DOIUrl":"https://doi.org/10.1210/clinem/dgad722","url":null,"abstract":"\u0000 \u0000 \u0000 The clinical relevance of the well-known association between thyroid cancer (TC) and breast cancer (BC) remains to be further defined.\u0000 \u0000 \u0000 \u0000 To investigate the effect of a history of BC on the prognosis of TC.\u0000 \u0000 \u0000 \u0000 This was a comparative cohort study of tumor behaviors and TC-specific mortality in 5,598 patients with papillary thyroid cancer (PTC) and 604 patients with follicular thyroid cancer (FTC), all with a history of BC (TC-BC patients), and their propensity score-matched TC patients without a history of BC (TCnoBC patients) in Surveillance, Epidemiology and End Results (SEER) 18.\u0000 \u0000 \u0000 \u0000 TC-specific mortality.\u0000 \u0000 \u0000 \u0000 Lower TC distant metastasis rates of 2.4% versus 3.0% in PTC and 6.1% versus 9.1% in FTC and TC-specific mortality rates of 1.3% versus 2.6% in PTC and 5.8% versus 8.4% in FTC were found in TC-BC patients versus matched TCnoBC patients (all P < 0.05). Comparing TC-BC patients with matched TCnoBC patients, hazard ratios (HRs) for mortality were 0.472 (95% CI 0.370 - 0.601) in PTC and 0.656 (95% CI 0.461 - 0.934) in FTC (all P < 0.05). Such HRs for mortality in PTC were 0.397 (95% CI 0.268 -0.588, P < 0.001) when TC occurred before BC versus 0.607 (95% CI 0.445 - 0.827, P = 0.002) when BC occurred before TC.\u0000 \u0000 \u0000 \u0000 This study demonstrates a robust protective effect of a history of BC on TC-specific patient survival, which has strong implications for more precise prognostication of TC in such patients.\u0000","PeriodicalId":222304,"journal":{"name":"The Journal of Clinical Endocrinology & Metabolism","volume":"90 24","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138586406","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Kyung-Hyun Park-Min, Sehwan Mun, Richard Bockman, Michelle M McDonald
{"title":"New Horizons- Translational Aspect of Osteomorphs","authors":"Kyung-Hyun Park-Min, Sehwan Mun, Richard Bockman, Michelle M McDonald","doi":"10.1210/clinem/dgad711","DOIUrl":"https://doi.org/10.1210/clinem/dgad711","url":null,"abstract":"\u0000 Osteomorphs are a newly described osteoclast lineage cell in mice, which are suggested to play a significant role in the maintenance of bone resorption. Pre-clinical investigations revealed that osteomorphs are generated through the fission of multinucleated bone-resorbing osteoclasts and can also re-fuse with existing osteoclasts. Modifications to RANKL signaling has been shown to alter cycles of fission and re-fusion of osteomorphs in mice. These novel findings were also shown to contribute to the rebound phenomenon after cessation of anti-RANKL therapy in mice. Moreover, the absence of osteomorph-specific genes in mice exhibits bone structural and quality phenotypes. Given these insights, it could be speculated that osteomorphs play a significant role in bone homeostasis, bone metabolic diseases, and response to therapeutics. In this review, we discuss these potential translational roles for osteomorphs. Importantly, we highlight the need for future pre-clinical and clinical studies to verify the presence of osteomorphs in humans and explore further the translational implications of this discovery.","PeriodicalId":222304,"journal":{"name":"The Journal of Clinical Endocrinology & Metabolism","volume":"3 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138592844","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}